09/13/2019
Centerline Biomedical wins $1.5 million NIH grant
Centerline Biomedical, Inc., a Cleveland Clinic spinoff company, has been awarded its third small business grant from the National Institutes of Health National Heart, Lung, and Blood Institute, with the Clinic as a subawardee, to support the company's navigation system for minimally invasive surgery.
09/06/2019
Cleveland Clinic's Medical Innovation Summit to focus on AI, drug discovery and more
Cleveland Clinic's 17th annual Medical Innovation Summit will tackle artificial intelligence, new drug discovery, nontraditional participants and personalization in health care, with a focus on the economics of it all, according to a news release.
09/05/2019
Cleveland Clinic’s 2019 Medical Innovation Summit to Focus on ‘Caring for Every Life Through Innovation’
Cleveland Clinic’s Medical Innovation Summit will bring more than 100 speakers and leaders from over 500 organizations and 20 countries to downtown Cleveland from Oct. 21 to 23, 2019, to focus on the task of “Caring for Every Life through Innovation.”
08/15/2019
Makers For Vets Program Returning To Northeast Ohio
Challenge America is again bringing its Makers for Veterans program to Northeast Ohio. Teams of engineers, doctors and other "makers" will work together at St. Edward High School to forge solutions to difficulties faced by disabled military veterans.
08/01/2019
Cleveland Clinic enters license agreement for breast cancer vaccine technology
Cleveland Clinic enters license agreement for breast cancer vaccine technology. Dr. Vincent Tuohy discusses the vaccine.
07/17/2019
Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology
Anixa Biosciences, Inc. (ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that it has established a strategic alliance and license agreement with Cleveland Clinic for an innovative breast cancer vaccine technology.
07/10/2019
Centerline Biomedical Receives FDA 510(k) Clearance for Intra-Operative Positioning System
Centerline Biomedical, Inc. (Centerline) has announced that the company has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its flagship product, the Intra-Operative Positioning System, IOPS.
06/20/2019
Xealth adds Atrium Health, Cleveland Clinic and MemorialCare to close $14m Series A
Xealth, the leading platform for connecting digital health, today announced that it has secured an additional $3 million in its Series A financing, bringing the amount raised in this round to $14 million total. New investors Atrium Health, Cleveland Clinic and MemorialCare Innovation Fund join McKesson Ventures, Novartis, Philips, ResMed, Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin health network. Investments from this round will be used to advance the development and deployment of the Xealth platform for digital health programs.
05/30/2019
Catapult, Prevent Biometrics Partner to Sync Safety, Performance Data
In conducting extensive trials with college and high school sports teams, Prevent Biometrics found value in syncing the impact data gleaned from its smart mouthguards with game video to provide context on collisions.
05/22/2019
TMAO and Heart Disease: The New Red Meat Risk?
Over the past several decades, public health experts and physicians have pinned a hefty portion of the blame for heart disease on saturated fat. That’s not without reason. The long-chain saturated fatty acids found in foods like steak, butter, and coconut oil raise artery-clogging low–density lipoprotein (LDL) cholesterol, a cause of atherosclerotic cardiovascular disease. At the same time, diets high in red meat have been strongly associated with heart disease and mortality.